SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $17,000 | -86.6% | 14,229 | -39.1% | 0.00% | – |
| Q2 2021 | $127,000 | +139.6% | 23,348 | +289.1% | 0.00% | – |
| Q3 2020 | $53,000 | +2550.0% | 6,000 | +2900.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 200 | +58.7% | 0.00% | – |
| Q4 2019 | $1,000 | – | 126 | +384.6% | 0.00% | – |
| Q3 2019 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 26 | -92.0% | 0.00% | – |
| Q3 2018 | $4,000 | -87.9% | 323 | -90.0% | 0.00% | – |
| Q2 2018 | $33,000 | -19.5% | 3,235 | +1.2% | 0.00% | – |
| Q1 2018 | $41,000 | -49.4% | 3,196 | -61.5% | 0.00% | -100.0% |
| Q4 2017 | $81,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |